查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
类风湿性关节炎的全球市场 - 市场占有率，规模，趋势，产业分析:各治疗法，各流通管道，各药物类型，各地区，市场区隔预测(2022年～2030年)
市场调查报告书
商品编码
1150074

类风湿性关节炎的全球市场 - 市场占有率，规模，趋势，产业分析:各治疗法，各流通管道，各药物类型，各地区，市场区隔预测(2022年～2030年)

Rheumatoid Arthritis Market Share, Size, Trends, Industry Analysis Report, By Therapy (Cell Therapy, DMARD, Symptomatic Treatment, Intermediate Corticosteroid Therapies); By Distribution Channel; By Drug Type; By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球类风湿性关节炎的市场规模，预计至2030年达到333亿美元。

本报告提供全球类风湿性关节炎市场相关调查分析，市场动态，市场区隔分析，地区分析，企业简介等系统性资讯。

目录

第1章 简介

  • 报告说明
    • 调查目的
    • 市场范围
    • 前提条件
  • 相关利益者

第2章 摘要整理

  • 市场概况

第3章 调查手法

  • 概要
    • 资料探勘
  • 资料来源
    • 一次来源
    • 二次来源

第4章 全球类风湿性关节炎市场洞察

  • 类风湿性关节炎:产业的概述
  • 类风湿性关节炎市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 波特的五力分析
    • 供给企业谈判力(中)
    • 新加入厂商的威胁(低)
    • 买方议价能力(中)
    • 替代品的威胁(中)
    • 现有企业间的竞争力(高)
  • PESTEL分析
  • 类风湿性关节炎市场产业趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球类风湿性关节炎市场:各药物类型

  • 主要的调查结果
  • 简介
    • 各药物类型:2018年～2030年
  • 医药品
    • 各类医药品，各地区:2018年～2030年
  • NSAID
    • 各NSAID，各地区:2018年～2030年
  • 止痛药
    • 各止痛药，各地区:2018年～2030年
  • DMARD
    • 各DMARD，各地区:2018年～2030年
  • 糖皮质激素
    • 各糖皮质激素，各地区:2018年～2030年
  • 生物医药品
    • 生物各类医药品，各地区:2018年～2030年
  • 生技药品
    • 各生技药品，各地区:2018年～2030年
  • 生物相似药
    • 各生物相似药，各地区:2018年～2030年

第6章 全球类风湿性关节炎市场:各流通管道

  • 主要的调查结果
  • 简介
    • 各流通管道:2018年～2030年
  • 院内药局
    • 各院内药局，各地区:2018年～2030年
  • 零售药局
    • 各零售药局，各地区:2018年～2030年
  • 药妆店
    • 各药妆店，各地区:2018年～2030年

第7章 全球类风湿性关节炎市场:各治疗法

  • 主要的调查结果
  • 简介
    • 各治疗法:2018年～2030年
  • 对症疗法
    • 各对症疗法，各地区:2018年～2030年
  • 中间皮质类固醇疗法
    • 各中间皮质类固醇疗法，各地区:2018年～2030年
  • 干细胞疗法/细胞疗法
    • 各干细胞疗法/细胞疗法，各地区:2018年～2030年
  • 缓解疾病性抗风湿药(DMARD)
    • 各缓解疾病性抗风湿药(DMARD)，各地区:2018年～2030年
  • 传统DMARD
    • 各传统DMARD，各地区:2018年～2030年
  • 生物学的DMARD
    • 各生物学的DMARD，各地区:2018年～2030年

第8章 全球类风湿性关节炎市场:各地区

  • 主要的调查结果
  • 简介
    • 类风湿性关节炎市场评估 - 各地区:2018年～2030年
  • 北美
    • 各药物类型:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各流通管道:2018年～2030年
    • 美国
    • 加拿大
  • 欧洲
    • 各药物类型:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各流通管道:2018年～2030年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 各药物类型:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各流通管道:2018年～2030年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
  • 中东、非洲
    • 各药物类型:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各流通管道:2018年～2030年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 南美
    • 各药物类型:2018年～2030年
    • 各治疗法:2018年～2030年
    • 各流通管道:2018年～2030年
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 竞争情形

  • 事业扩张和收购的分析
    • 事业扩张
    • 收购
  • 联盟/合作/协定/展示会

第10章 企业简介

  • AbbVie Incorporation
  • Amgen Corporation
  • Amneal Pharmaceuticals LLC
  • Bristol-Myers Squibb Company
  • Cipla, Inc
  • Dr. Reddy's Laboratories
  • Norbrook Laboratories Ltd
  • Roxane Laboratories Inc
  • Pfizer Inc
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd
  • Sobi Inc
  • Teva Pharmaceuticals, Inc
Product Code: PM1371

The global rheumatoid arthritis market size is expected to reach USD 33.30 billion by 2030, according to a new study by Polaris Market Research. The report "Rheumatoid Arthritis Market Share, Size, Trends, Industry Analysis Report, By Therapy (Cell Therapy, DMARD, Symptomatic Treatment, Intermediate Corticosteroid Therapies); By Distribution Channel; By Drug Type; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is being fueled by a rise in the number of arthritis and associated joint problems. Rheumatoid arthritis is on the rise as a result of the shift to an unhealthy lifestyle, rising metabolic disorders & age, family history of joint diseases, and increased obesity. As per the Centers for Disease Control and Prevention (CDC), millions of people in the US have severe pain due to arthritis each year. 15 million adults with arthritis report having severe joint pain as a result of their disease.

To strengthen their position in this market, manufacturers are concentrating on partnerships with other competitors. In January 2022, the Queen Mary University of London and Exagen Inc. announced a partnership and exclusive license agreement. The collaboration's main goal is to customize the choice of treatment agents for Rheumatoid Arthritis (RA) patients by developing and refining patent-pending personalized medicine techniques based on RNA expression patterns.

Both parties will work together to develop the patent-pending assays, which will eventually lead to the commercialization of cutting-edge molecular assays that divide patients into groups based on the expression of particular genes in synovial tissue biopsies. Thus, these factors are assisting the market growth over the forecast period.

Furthermore, in comparison to the general population, women have a higher risk of developing certain autoimmune illnesses. For instance, as per the Department of Health & Human Services (HHS) in the US, RA is the fourth-largest cause of disability among women in the US and are the eighth-leading cause of mortality for women between the ages of 15 and 64. The prevalence of rheumatoid arthritis (RA) in the US is high due to which the demand and adoption of treatment have increased. In rheumatoid arthritis (RA), the immune system attacks the joint.

The development of complex biologics, rising purchasing power, rising healthcare costs, and improved accessibility to high-quality medicines for middle-class and low-income families globally are all important causes. On the other hand, the global market is anticipated to grow swiftly and change the market picture due to improved treatment for early treatment and screening of rheumatoid arthritis. As a result, the global market for rheumatoid arthritis medications is seeing rapid growth, which is opening up attractive potential.

Rheumatoid Arthritis Market Report Highlights

The online pharmacy segment is anticipated to grow at a significant CAGR over the forecast period. This can be attributed to the expanding e-commerce market and rising popularity of online drug sales following the COVID-19 virus spread. The growing use of smartphones and the internet is helping the segmental expansion even further.

NSAIDs drug segment accounted for a major share of the global revenue share. Non-steroidal anti-inflammatory drugs (NSAIDs) are among them and are frequently used to treat the symptoms of rheumatic disorders, which are characterized by a variety of acute pain symptoms and long-term musculoskeletal discomfort. These medications' main result is to lessen acute inflammation, which lessens pain and enhances overall performance.

Asia Pacific is expected to grow at a highest CAGR over the projected period. Due to the substantial population base vulnerable to RA, the growth of the R&D sector, and the rising adoption of RA drugs, the region offers profitable positions for major players operating in the market

The global market players with a global presence includes AbbVie Incorporation, Sun Pharmaceutical Industries Ltd., Sobi Inc., and Teva Pharmaceuticals, Inc.

Polaris Market Research has segmented the rheumatoid arthritis market report based on drug type, distribution channel, therapy, and region:

Rheumatoid Arthritis, Therapy Outlook (Revenue - USD Billion, 2018 - 2030)

Symptomatic Treatment

Intermediate Corticosteroid Therapies

Stem Cell Therapy/ Cell Therapy

Disease Modifying Anti-rheumatic Drug (DMARD)

Conventional DMARDs

Biological DMARDs

Rheumatoid Arthritis, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Rheumatoid Arthritis, Drug Type Outlook (Revenue - USD Billion, 2018 - 2030)

Pharmaceuticals

NSAIDs

Analgesics

DMARDs

Glucocorticoids

Biopharmaceuticals

Biologics

Biosimilars

Rheumatoid Arthritis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Rheumatoid Arthritis Market Insights

  • 4.1. Rheumatoid Arthritis - Industry Snapshot
  • 4.2. Rheumatoid Arthritis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising FDA approvals for the treatment of rheumatoid arthritis
      • 4.2.1.2. Increase in healthcare expenditure worldwide
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of access to treatment of rheumatoid arthritis in underdeveloped countries
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Rheumatoid Arthritis Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Rheumatoid Arthritis Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 5.3. Pharmaceuticals
    • 5.3.1. Global Rheumatoid Arthritis Market, by Pharmaceuticals, by Region, 2018 - 2030 (USD Billion)
  • 5.4. NSAIDs
    • 5.4.1. Global Rheumatoid Arthritis Market, by NSAIDs, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Analgesics
    • 5.5.1. Global Rheumatoid Arthritis Market, by Analgesics, by Region, 2018 - 2030 (USD Billion)
  • 5.6. DMARDs
    • 5.6.1. Global Rheumatoid Arthritis Market, by DMARDs, by Region, 2018 - 2030 (USD Billion)
  • 5.7. Glucocorticoids
    • 5.7.1. Global Rheumatoid Arthritis Market, by Glucocorticoids, by Region, 2018 - 2030 (USD Billion)
  • 5.8. Biopharmaceuticals
    • 5.8.1. Global Rheumatoid Arthritis Market, by Biopharmaceuticals, by Region, 2018 - 2030 (USD Billion)
  • 5.9. Biologics
    • 5.9.1. Global Rheumatoid Arthritis Market, by Biologics, by Region, 2018 - 2030 (USD Billion)
  • 5.10. Biosimilars
    • 5.10.1. Global Rheumatoid Arthritis Market, by Biosimilars, by Region, 2018 - 2030 (USD Billion)

6. Global Rheumatoid Arthritis Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Rheumatoid Arthritis Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Retail Pharmacies
    • 6.4.1. Global Rheumatoid Arthritis Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Drug Stores
    • 6.5.1. Global Rheumatoid Arthritis Market, by Drug Stores, by Region, 2018 - 2030 (USD Billion)

7. Global Rheumatoid Arthritis Market, by Therapy

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • 7.3. Symptomatic Treatment
    • 7.3.1. Global Rheumatoid Arthritis Market, by Symptomatic Treatment, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Intermediate Corticosteroid Therapies
    • 7.4.1. Global Rheumatoid Arthritis Market, by Intermediate Corticosteroid Therapies, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Stem Cell Therapy/ Cell Therapy
    • 7.5.1. Global Rheumatoid Arthritis Market, by Stem Cell Therapy/ Cell Therapy, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Disease Modifying Anti-rheumatic Drug (DMARD)
    • 7.6.1. Global Rheumatoid Arthritis Market, by Disease Modifying Anti-rheumatic Drug (DMARD), by Region, 2018 - 2030 (USD Billion)
  • 7.7. Conventional DMARDs
    • 7.7.1. Global Rheumatoid Arthritis Market, by Conventional DMARDs, by Region, 2018 - 2030 (USD Billion)
  • 7.8. Biological DMARDs
    • 7.8.1. Global Rheumatoid Arthritis Market, by Biological DMARDs, by Region, 2018 - 2030 (USD Billion)

8. Global Rheumatoid Arthritis Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Rheumatoid Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 8.3. Rheumatoid Arthritis Market - North America
    • 8.3.1. North America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.3.2. North America: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.3.3. North America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.3.4. Rheumatoid Arthritis Market - U.S.
      • 8.3.4.1. U.S.: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.3.4.2. U.S.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.3.4.3. U.S.: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.3.5. Rheumatoid Arthritis Market - Canada
      • 8.3.5.1. Canada: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.3.5.2. Canada.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.3.5.3. Canada: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.4. Rheumatoid Arthritis Market - Europe
    • 8.4.1. Europe: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.4.2. Europe.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.4.3. Europe: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.4. Rheumatoid Arthritis Market - UK
      • 8.4.4.1. UK: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.4.2. UK.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.4.3. UK: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.5. Rheumatoid Arthritis Market - France
      • 8.4.5.1. France: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.5.2. France.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.5.3. France: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.6. Rheumatoid Arthritis Market - Germany
      • 8.4.6.1. Germany: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.6.2. Germany.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.6.3. Germany: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.7. Rheumatoid Arthritis Market - Italy
      • 8.4.7.1. Italy: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.7.2. Italy.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.7.3. Italy: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.8. Rheumatoid Arthritis Market - Spain
      • 8.4.8.1. Spain: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.8.2. Spain.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.8.3. Spain: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.9. Rheumatoid Arthritis Market - Netherlands
      • 8.4.9.1. Netherlands: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.9.2. Netherlands.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.9.3. Netherlands: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.4.10. Rheumatoid Arthritis Market - Russia
      • 8.4.10.1. Russia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.4.10.2. Russia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.4.10.3. Russia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.5. Rheumatoid Arthritis Market - Asia Pacific
    • 8.5.1. Asia Pacific: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.5.2. Asia Pacific.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.5.3. Asia Pacific: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.4. Rheumatoid Arthritis Market - China
      • 8.5.4.1. China: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.4.2. China.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.4.3. China: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.5. Rheumatoid Arthritis Market - India
      • 8.5.5.1. India: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.5.2. India.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.5.3. India: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.6. Rheumatoid Arthritis Market - Malaysia
      • 8.5.6.1. Malaysia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.6.2. Malaysia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.6.3. Malaysia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.7. Rheumatoid Arthritis Market - Japan
      • 8.5.7.1. Japan: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.7.2. Japan.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.7.3. Japan: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.8. Rheumatoid Arthritis Market - Indonesia
      • 8.5.8.1. Indonesia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.8.2. Indonesia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.8.3. Indonesia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.5.9. Rheumatoid Arthritis Market - South Korea
      • 8.5.9.1. South Korea: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.5.9.2. South Korea.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.5.9.3. South Korea: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.6. Rheumatoid Arthritis Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.6.2. Middle East & Africa.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.6.3. Middle East & Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.4. Rheumatoid Arthritis Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.5. Rheumatoid Arthritis Market - UAE
      • 8.6.5.1. UAE: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.5.2. UAE.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.5.3. UAE: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.6. Rheumatoid Arthritis Market - Israel
      • 8.6.6.1. Israel: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.6.2. Israel.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.6.3. Israel: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.6.7. Rheumatoid Arthritis Market - South Africa
      • 8.6.7.1. South Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.6.7.2. South Africa.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.6.7.3. South Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.7. Rheumatoid Arthritis Market - Latin America
    • 8.7.1. Latin America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
    • 8.7.2. Latin America.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
    • 8.7.3. Latin America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.7.4. Rheumatoid Arthritis Market - Mexico
      • 8.7.4.1. Mexico: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.7.4.2. Mexico.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.7.4.3. Mexico: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.7.5. Rheumatoid Arthritis Market - Brazil
      • 8.7.5.1. Brazil: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.7.5.2. Brazil.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.7.5.3. Brazil: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 8.7.6. Rheumatoid Arthritis Market - Argentina
      • 8.7.6.1. Argentina: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
      • 8.7.6.2. Argentina.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
      • 8.7.6.3. Argentina: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Incorporation
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amgen Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Amneal Pharmaceuticals LLC
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bristol-Myers Squibb Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Cipla, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dr. Reddy's Laboratories
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Norbrook Laboratories Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Roxane Laboratories Inc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Pfizer Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi SA
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Sun Pharmaceutical Industries Ltd
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sobi Inc
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Teva Pharmaceuticals, Inc
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables

  • Table 1 Global Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 2 Global Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 3 Global Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 4 Rheumatoid Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 5 North America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 6 North America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 7 North America: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 8 U.S.: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 9 U.S.: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 11 Canada: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 12 Canada: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 13 Canada: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 14 Europe: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 15 Europe: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 16 Europe: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 17 UK: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 18 UK: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 19 UK: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 20 France: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 21 France: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 22 France: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 26 Italy: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 27 Italy: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 Italy: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 29 Spain: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 30 Spain: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31 Spain: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 32 Netherlands: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 33 Netherlands: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34 Netherlands: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 35 Russia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 36 Russia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37 Russia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 39 Asia Pacific: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 41 China: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 42 China: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43 China: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 44 India: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 45 India: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46 India: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 47 Malaysia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 48 Malaysia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49 Malaysia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 50 Japan: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 51 Japan: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Japan: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 53 Indonesia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 54 Indonesia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 55 Indonesia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 56 South Korea: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 57 South Korea: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 58 South Korea: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 64 Saudi Arabia: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 65 UAE: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 66 UAE: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 67 UAE: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 68 Israel: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 69 Israel: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 70 Israel: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 71 South Africa: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 72 South Africa: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 73 South Africa: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 74 Latin America: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 75 Latin America: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 76 Latin America: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 77 Mexico: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 78 Mexico: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 79 Mexico: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 80 Brazil: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 81 Brazil: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 83 Argentina: Rheumatoid Arthritis Market, by Drug Type, 2018 - 2030 (USD Billion)
  • Table 84 Argentina: Rheumatoid Arthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85 Argentina: Rheumatoid Arthritis Market, by Therapy, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Rheumatoid Arthritis Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Distribution Channel

Figure 7. Global Rheumatoid Arthritis Market, by Distribution Channel, 2021 & 2030 (USD Billion)

Figure 8. Market by Drug Type

Figure 9. Global Rheumatoid Arthritis Market, by Drug Type, 2021 & 2030 (USD Billion)

Figure 10. Market by Therapy

Figure 11. Global Rheumatoid Arthritis Market, by Therapy, 2021 & 2030 (USD Billion)

Figure 12. Rheumatoid Arthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 13. Strategic Analysis - Rheumatoid Arthritis Market